|
|
|
Biovail Corporation is a pioneer and world leader in the development, manufacture and marketing of controlled-release pharmaceutical products. Biovail's shares are listed on the New York (NYSE) and Toronto Stock Exchange (TSX).
 The Biovail Press Room features the latest news releases and scientific and financial news on the Company and its products, as well as a select archive of news releases and related materials.
Contact Information
Media inquiries are welcome and should be directed to:
Nelson Isabel, CFA
Vice-President, Investor Relations and Corporate Communications
Phone: 905.286.3000
Fax: 905.286.3050
Email: ir@biovail.com
To access news releases and articles, select a headline from below and click.
Go to News Archive
|
|
|
